Grant Whitfield did not speak again for almost a minute.
He sat with the note open in front of him, one hand pressed flat against the conference table as if keeping the document from moving. Christopher watched him instead of me now. That told me more than anything Grant could have said aloud.
Christopher had spent years believing that difficult situations became manageable once he handed them to the right professional.
Grant was one of those professionals.
"What does it mean?" Christopher asked.
Grant looked toward Deborah.
"Assuming the documentation is authentic and the payment history is what counsel represents, we need to evaluate the conversion calculation."
"It means exactly what it says," Deborah replied.
Christopher turned on me.
"You're trying to take my company."
"No."
"Don't do that."
"Do what?"
"That calm thing where you pretend words don't mean what they mean."
I folded my hands.
"The company borrowed money from me. The company stopped paying. The agreement describes what happens after prolonged default."
"We were married."
"Yes."
"You benefited from Vextor succeeding."
"Also yes."
"So now you're going to use something from eight years ago to punish me?"
Deborah started to speak.
I touched her sleeve lightly.
"This isn't punishment," I said. "It's an obligation you ignored."
Christopher laughed once. There was no humor in it.
"You let it sit there."
"I did."
"For years."
"Yes."
"Why?"
That question interested me.
Not because he deserved the answer.
Because I had asked it of myself.
Why had I allowed a legally enforceable note to remain unpaid while Vextor's valuation multiplied?
Partly because we were married.
Partly because I believed our interests were aligned.
Partly because I thought collecting aggressively from my husband's company would amount to taking money from one shared pocket and placing it into another.
And partly because Christopher had trained both of us to treat the things I contributed as background infrastructure.
Useful.
Reliable.
Always available.
"I thought we were building the same life," I said.
His expression changed for half a second.
Then anger returned.
Grant closed the folder.
"We'll need copies."
"You'll receive them electronically," Deborah said.
Christopher pushed back his chair.
"This is extortion."
"No," Grant said sharply.
Christopher turned.
Grant's voice remained low.
"Don't use that word."
Christopher stared at him.
Grant continued.
"If the instrument is valid, and if the default occurred as reflected here, then this is a contractual dispute. Calling it something else in this room helps nobody."
I had known Grant socially for years. I had watched him laugh at Christopher's stories, drink his wine, celebrate Vextor's milestones, and praise his instincts.
That morning, for the first time, Grant was not Christopher's friend.
He was his lawyer.
Christopher seemed to understand the difference too.
He stood.
"This meeting is over."
Deborah remained seated.
"We haven't discussed the revised settlement proposal."
"I said we're done."
Grant gathered the folder.
"We'll respond."
Christopher left without looking at me again.
The door closed.
Deborah waited until we heard the elevator bell outside.
Then she released a breath.
"That went better than it could have."
"Christopher thinks I engineered the note."
"He will continue thinking that because the alternative is admitting he signed an important contract without reading it."
I looked at the closed door.
"How much equity?"
"We don't know yet."
"You have an estimate."
She hesitated.
"I have a range."
"Deborah."
She removed her glasses.
"Depending on the valuation mechanism, subsequent financing adjustments, and whether their counsel finds an enforceability issue, enough that Vextor's board will care."
"How much is enough?"
"Potentially more than ten percent."
I sat very still.
Vextor was no longer an eight-person company running out of payroll money.
At its latest internal valuation, ten percent represented millions.
But the financial value was not the part that changed everything.
Vextor's capitalization had become complicated over the years. Preferred shares. Employee options. Investor rights. Board thresholds. Protective provisions.
A forgotten block of equity could affect control.
I understood that immediately.
Christopher would understand it once Grant explained it.
My phone vibrated.
A message from Deborah's paralegal.
Petrosyan & Ashford had requested an urgent call.
Deborah read the same message on her phone.
"Do you have twenty minutes?"
"I have the afternoon."
We moved to her office.
She closed the door and connected the forensic accountants through a secure conference line.
Aram Petrosyan spoke first.
His voice was methodical, almost dry, which I appreciated.
"We've substantially completed the vendor tracing you requested."
"Halvard?" Deborah asked.
"Halvard and related entities."
I looked at the speaker.
"Related entities?"
"Yes."
Paper shifted on his end.
"Halvard Strategic Partners was organized in Nevada in August 2022. The registered agent is commercial. The listed manager is a Wyoming holding company called Creston Advisory Holdings."
"Who owns Creston?"
"That's where it becomes interesting."
Deborah picked up a pen.
Aram continued.
"Creston was formed by a corporate services provider, but bank onboarding records identify a beneficial owner."
"Who?"
"Michelle Rasmussen."
For a few seconds, nobody spoke.
I had expected the answer.
At least, I thought I had.
But expecting a fact and hearing it stated by a forensic accountant are different experiences.
Michelle.
My closest friend.
The woman who had driven me home from fertility procedures.
The woman who had known exactly what those procedures cost us.
The woman carrying Christopher's children.
"You're certain?" Deborah asked.
"We have documentation."
"What was Halvard doing for Vextor?"
"That's the problem. We cannot identify legitimate services commensurate with the payments."
"How much?"
"Two hundred six thousand four hundred dollars directly to Halvard."
I closed my eyes briefly.
There was the number I already knew.
Then Aram said, "But Halvard is not the full amount."
I opened them.
"What else?"
"Three additional vendors appear connected."
He named them.
North Vale Market Research.
Sierra Praxis LLC.
Carden Biomedical Consulting.
I had seen the names in Vextor's records but never associated them with anything suspicious. Each looked plausible. Each received modest payments scattered across different periods.
Combined, the four entities had received just under $684,000.
Deborah stopped writing.
"From Vextor?"
"Yes."
"For what purpose?"
"That's still under review."
"Any employees?"
"None we can verify."
"Contracts?"
"Generic consulting agreements."
"Deliverables?"
"Minimal."
I thought about Christopher's pride in Vextor's controls.
The audits.
The board presentations.
The way he had once described fraud as something committed by stupid people who believed accountants did not know how to follow numbers.
"Who approved the payments?" I asked.
There was a pause.
"Most were approved under executive authority."
"Christopher."
"His credentials, yes."
I stared at the phone.
Deborah asked the next question.
"Could someone else have used them?"
"Possible. We don't have enough evidence to say otherwise."
"What connects the other entities to Michelle?"
"Different pathways. One shares a mailing service. Another used the same bank-contact number during onboarding. Carden Biomedical is more complicated."
"How?"
Aram hesitated.
"I'd prefer to send the supporting documents before characterizing that."
"Characterize it carefully," Deborah said.
"Carden appears to have paid substantial sums to a fertility clinic in Arizona."
The room became very quiet.
I felt the air change around me.
"What clinic?"
He gave the name.
I knew it.
Not because I had been treated there.
Because Tucson had appeared eleven times on Christopher's calendar.
Deborah looked directly at me.
"Victoria?"
"I'm fine."
I was not fine.
But the sentence had become useful.
Aram continued.
"We're tracing whether those payments were for medical services, administrative fees, or something else. Patient information is obviously protected, and we're not attempting to obtain private medical records improperly. We're following corporate money."
"Understood," Deborah said.
"There's more."
I looked down at my hands.
Aram explained that Vextor had classified several payments as product-development expenses. Carden Biomedical invoiced the company for something described as reproductive biosensor feasibility research.
I almost laughed.
Not because anything was funny.
Because the description was so audaciously convenient.
Vextor made industrial sensor systems.
It had never operated a reproductive-health division.
"What exactly did Carden deliver?" I asked.
"Three PDF reports."
"How long?"
"Between four and seven pages each."
"Technical?"
"Superficially."
"Original?"
"We're checking."
A cold sensation moved through me.
"Check whether the language was copied from publicly available research."
"We already are."
"Also compare the metadata."
There was another pause.
Aram's voice changed slightly.
"We did."
"And?"
"One document appears to have been created on a laptop registered to Michelle Rasmussen."
Deborah set down her pen.
I looked toward the window.
A bus moved along University Avenue below us.
People crossed the street.
Somebody walked a golden retriever past a pharmacy.
Normal life continued with offensive efficiency.
"Anything else?" I asked.
"One more item."
Of course there was.
There was always one more item.
"Last year," Aram said, "Vextor reimbursed approximately eighty-four thousand dollars to an executive discretionary account."
"Christopher's?"
"Yes."
"For?"
"Travel, lodging, consulting-related meetings, and miscellaneous business development."
"Tucson?"
"Among other locations."
Deborah leaned forward.
"Can you establish personal misuse?"
"Not yet."
"Then don't characterize it as misuse."
"Agreed."
I appreciated her precision.
Facts first.
Always.
We ended the call after arranging delivery of the preliminary report.
For several minutes, Deborah and I sat without speaking.
Then she said, "We need to separate the divorce from the corporate issue."
"They're already connected."
"Factually, yes. Strategically, they need different lanes."
"I understand."
"Do you?"
I looked at her.
"If Vextor money paid expenses associated with Christopher's affair, that's one issue. If company money financed fertility treatment for Michelle, that's worse. If false vendors were created to conceal those payments, we're entering territory that goes beyond marital misconduct."
"I know."
"His board may have reporting obligations."
"I know."
"And you cannot use potential corporate misconduct as leverage to extract a better divorce settlement."
"I know."
Her eyes stayed on mine.
"Good."
My phone vibrated again.
This time the message came from Christopher.
We need to talk without attorneys.
I showed Deborah.
"No," she said.
"I wasn't going to."
Another message arrived.
This note thing can be solved. Don't make this uglier than it already is.
I read it twice.
Not because the words were complicated.
Because Christopher still believed the note was the most dangerous thing I knew.
For the first time since discovering the affair, I felt something close to pity.
He had no idea where the accountants had already reached.
That evening I returned to my apartment and opened the preliminary report.
The first forty pages concerned ownership records, vendor registrations, payment histories, and authorization chains.
Then I reached Carden Biomedical.
Attached behind its incorporation documents was a bank onboarding form.
Beneficial owner: Daniel Rasmussen.
I stopped.
Michelle's father.
I had known Daniel Rasmussen for twenty-three years.
He was a retired obstetrician.
I read further.
Carden's bank account had received money from Vextor.
Carden had then paid the Arizona fertility clinic.
But the amounts did not simply cover medical invoices.
Large transfers had also gone to Michelle.
And one payment, made six weeks before her pregnancy was confirmed, had gone somewhere else entirely.
A genetics laboratory in Phoenix.
I stared at the line.
Christopher had told Michelle in his messages that "after everything they had endured," the pregnancy felt miraculous.
Miraculous pregnancies do not usually require corporate vendors, shell companies, fertility clinics, and genetics laboratories.
Whatever had happened in Tucson had been planned.
And Christopher had apparently used Vextor's money to plan it.
Click Here to continue read next: PART6: Michelle Told Me the Twins Proved Christopher Had Never Been the Problem, but One Laboratory Invoice Made Her Cruelty Collapse
Ninety Minutes After Our Marriage Ended, Christopher Sent Me a Photograph He Expected Would Finally Make Me Break
Part 5 of 12
